B. Kevin Park
- Hepatology top 1%
- Liver physiology and pathology 9
- Pharmacology top 0.2%
- Drug-Induced Hepatotoxicity and Protection 15
- Pharmacogenetics and Drug Metabolism 8
- Drug-Induced Adverse Reactions 6
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection 15
- Pharmacogenetics and Drug Metabolism 8
- Drug-Induced Adverse Reactions 6
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 4
- Epidemiology top 10%
-
- Pluripotent Stem Cells Research 5
- Genomics, phytochemicals, and oxidative stress 3
-
- Pancreatic function and diabetes 4
- Co-authors
- Neil R. KitteringhamChristopher E. GoldringRosalind E. JenkinsHartmut JaeschkeRowena Sison‐YoungMagnus Ingelman‐SundbergEwa EllisXiaoli Meng
- Cited by
- HepatologyPharmacology
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
B. Kevin Park
35 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Hepatology 813
- Pharmacology 749
- Pharmacology 240
- Oncology 378
- Epidemiology 407
Countries citing papers authored by B. Kevin Park
This map shows the geographic impact of B. Kevin Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Kevin Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Kevin Park more than expected).
Fields of papers citing papers by B. Kevin Park
This network shows the impact of papers produced by B. Kevin Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Kevin Park. The network helps show where B. Kevin Park may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B. Kevin Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2020 | 126 | |
| 3 | 2018 | 22 | |
| 4 | 2017 | 22 | |
| 5 | Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and diseasebreakdown → | 2016 | 517 |
| 6 | 2016 | 95 | |
| 7 | 2015 | 72 | |
| 8 | 2015 | 49 | |
| 9 | 2015 | 151 | |
| 10 | 2014 | 73 | |
| 11 | 2013 | 102 | |
| 12 | 2013 | 75 | |
| 13 | 2011 | 102 | |
| 14 | 2011 | 7 | |
| 15 | 2011 | 175 | |
| 16 | 2010 | 48 | |
| 17 | 2010 | 30 | |
| 18 | 2009 | 33 | |
| 19 | 2008 | 104 | |
| 20 | 1994 | 62 |
About B. Kevin Park
B. Kevin Park is a scholar working on Pharmacology, Hepatology and Pharmacology, having authored 36 papers that have together received 2.4k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (15 papers), Liver physiology and pathology (9 papers), Pharmacogenetics and Drug Metabolism (8 papers), Drug-Induced Adverse Reactions (6 papers), Pluripotent Stem Cells Research (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Pancreatic function and diabetes (4 papers) and Genomics, phytochemicals, and oxidative stress (3 papers). The work is most often cited by research in Hepatology (813 citations), Pharmacology (749 citations) and Pharmacology (240 citations). B. Kevin Park has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Neil R. Kitteringham, Christopher E. Goldring, Rosalind E. Jenkins, Hartmut Jaeschke, Rowena Sison‐Young, Magnus Ingelman‐Sundberg, Ewa Ellis, Xiaoli Meng, Dean J. Naisbitt and Catherine C. Bell. Their work appears in journals such as Hepatology, Scientific Reports and Cell stem cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.